Attached files
| file | filename |
|---|---|
| EX-99.1 - QSAM Biosciences, Inc. | ex99-1.htm |
United
States
Securities and Exchange Commission
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15[d] of the Securities Exchange Act of 1934
April 3, 2018
Date of Report
Q2EARTH, INC.
(Exact name of Registrant as specified in its Charter)
| Delaware | 000-55148 | 20-1602779 |
| (State
or Other Jurisdiction of Incorporation) |
(Commission
File Number) |
(I.R.S.
Employer Identification No.) |
420 Royal Palm Way, #100
Palm Beach, FL 33480
(Address of Principal Executive Offices)
(561) 693-1423
(Registrant’s Telephone Number, including area code)
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see general instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14-a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On April 3, 2018, Q2Earth, Inc. sent an update letter to shareholders through a general press release distribution. That press release is being filed herewith.
Item 9.01 Financial Statements and Exhibits.
(b) Exhibits.
| 99.1 | Press Release distributed April 3, 2018 |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.
Q2EARTH, INC.
| Date: April 3, 2018 | By: | /s/ Christopher Nelson | |
| Christopher Nelson | |||
| President and General Counsel | |||
| 3 |